Zhangjiagang Zhuoyuan Investment Partnership (Limited Partnership) agreed to acquire 5.24% stake in Porton Pharma Solutions Ltd. (SZSE:300363) from Ju Nianfeng, Tao Rong, and Zhang Hebing for CNY 1.04 billion on December 18, 2020. Under the terms of the transaction Zhangjiagang Zhuoyuan Investment Partnership (Limited Partnership) will acquire 28.3 million shares for CNY36.97 per share. Ju Nianfeng transfered 8.4 million shares, accounting for 1.56% of share capital, Tao Rong transferred 11.4 million shares, accounting for 2.12% of share capital, Zhang Hebing transferred 8.4 million Shares, accounting for 1.56% of share capital. Post completion of the transaction, Ju Nianfeng, Tao Rong and Zhang Hebing will hold 10.90%, 8.18% and 7.75% equity of the company respectively. Prior to the transaction Zhangjiagang Zhuoyuan Investment Partnership (Limited Partnership) did not hold any stake in Porton Pharma Solutions Ltd. Zhangjiagang Zhuoyuan Investment Partnership (Limited Partnership) completed the acquisition of 5.24% stake in Porton Pharma Solutions Ltd. (SZSE:300363) from Ju Nianfeng, Tao Rong, and Zhang Hebing on February 2, 2021.